BioPharma company reports $4.8bn net sales.
Pharmaceutical giant pays US authorities in relation to misidentified products.
Loss comes since to loss of a major client, according to CEO.
FDA warns of adverse effects in children consistent with belladona toxicity.
Pharmaceutical giant reports $8.86 billion net sales
Private investor group commits £30m.
Genmab to create new human antibodies for central nervous system disorders.
Prostate cancer research shows promise.
Secure File Transfer combines ease of use with regulation standard security and tracking.
Dendritic cell-based vaccine for treatment of glioblastoma multiforme.
New providers complain of barriers to competition.
Three-year grant will help aid detection and characterisation of tumour cells.
Security company's new offering designed to safeguard endpoint systems with a single solution manage
Revenue fell from $8.94m to $6.12m from 2009 to 2010.
Income from operations was $12.8m for the full year ended 30 June 2010.
Taro manufactures topical creams and ointments.
Polydex reported sales of $986,349, against $1.23m in 2009.
The new partnership is intended to develop diabeties medicine.
Sourcing, quality assurance, regulatory support, marketing and distribution company say economy "sti
New drug effective against both common strains of the malaria parasite.
Settlement follows a US federal investigation.
T-DM1 had demonstrated decreased tumors in one-third of female breast cancer sufferers in previous t
The centre is part of the company's €100m expansion project in China
New drug will allow treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid le
Actelion is entitled to pay a sum of an upfront and milestone payments of C$3.7m to Basilea
Novartis Pharma has received the go ahead for new blood pressure drug
Failed flotation attempts and search for long-term stability prompt sale of UK medical groups
Net sales rise slightly to $97.97m, while gross profits fall to $56.6m
China BCT has seen a revenue increase of 43 per cent.
Bioanalytical Systems has reported a net income rise for quarter 3 of 2010